Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrien Picod

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Hypertension (Dallas, Tex. : 1979)|February 9, 2024
Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin PeptidesAdrien Picod, Sandrine Placier, Magali Genest, et al.
Frontiers in Medicine|December 19, 2022
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: <i>Post-hoc</i> analyses of the phase II adrenomedullin and outcome in septic shock 2 trialDirk van Lier, Adrien Picod, Gernot Marx, et al.
Critical Care Explorations|October 15, 2024
Alterations in the Renin-Angiotensin System in Experimental Septic ShockBruno Garcia, Benoit Ter Schiphorst, Fuhong Su, et al.
Mabs|May 21, 2026
Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3Magali Genest, Dirk Van Lier, Theo Ikenna Uba, et al.
Mabs|May 21, 2026
Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primatesDirk van Lier, Magali Genest, Adrien Picod, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2018
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience StudyAdrien Picod, Agnès Bonnin, Giorgia Battipaglia, et al.
Intensive Care Medicine Experimental|June 7, 2024
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injuryBruno Garcia, Benoit Ter Schiphorst, Karine Santos, et al.
Iscience|March 18, 2026
Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stressNoma Assad, Hugo Nordin, Alexis Nguyen, et al.
Critical Care (London, England)|May 20, 2025
Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO studyKhalil Chaïbi, Adrien Picod, Marouane Boubaya, et al.
Haematologica|January 8, 2026
Ethnicity affects relapse-free survival in immune-mediated thrombotic thrombocytopenic purpuraJúlia Weisinger, Florian Blanchard, Benoit Suzon, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Hypertension (Dallas, Tex. : 1979)|February 9, 2024
Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin PeptidesAdrien Picod, Sandrine Placier, Magali Genest, et al.
Frontiers in Medicine|December 19, 2022
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: <i>Post-hoc</i> analyses of the phase II adrenomedullin and outcome in septic shock 2 trialDirk van Lier, Adrien Picod, Gernot Marx, et al.
Critical Care Explorations|October 15, 2024
Alterations in the Renin-Angiotensin System in Experimental Septic ShockBruno Garcia, Benoit Ter Schiphorst, Fuhong Su, et al.
Mabs|May 21, 2026
Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3Magali Genest, Dirk Van Lier, Theo Ikenna Uba, et al.
Mabs|May 21, 2026
Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primatesDirk van Lier, Magali Genest, Adrien Picod, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2018
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience StudyAdrien Picod, Agnès Bonnin, Giorgia Battipaglia, et al.
Intensive Care Medicine Experimental|June 7, 2024
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injuryBruno Garcia, Benoit Ter Schiphorst, Karine Santos, et al.
Iscience|March 18, 2026
Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stressNoma Assad, Hugo Nordin, Alexis Nguyen, et al.
Critical Care (London, England)|May 20, 2025
Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO studyKhalil Chaïbi, Adrien Picod, Marouane Boubaya, et al.
Haematologica|January 8, 2026
Ethnicity affects relapse-free survival in immune-mediated thrombotic thrombocytopenic purpuraJúlia Weisinger, Florian Blanchard, Benoit Suzon, et al.
Pageof 3